About this item:

73 Views | 55 Downloads

Author Notes:

jfalcala@gmail.com

Conceptualization, J.F.A.-D.; J.L.-M.; J.D.-L.; Literature Review, A.P.A.d.L.; L.L.-P.; Writing—Original draft preparation, A.P.A.d.L.; L.L.-P.; J.D.-L.; Writing—review and editing, A.P.A.d.L; A.A.; J.F.A-D.; J.D.- L.; Supervision, A.A.; J.L.-M.; J.D.-L. All authors have read and agreed to the published version of the manuscript.

The authors declare no conflict of interest.

Subjects:

Research Funding:

This research received no external funding.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Nutrition & Dietetics
  • ceruloplasmin
  • coronary heart disease
  • inflammation
  • SENSITIVE PLASMA-PROTEINS
  • DENSITY-LIPOPROTEIN OXIDATION
  • MYOCARDIAL-INFARCTION
  • SERUM CERULOPLASMIN
  • CARDIOVASCULAR RISK
  • NITRIC-OXIDE
  • UPDATE
  • COPPER
  • LEVEL
  • ASSOCIATION

Ceruloplasmin and Coronary Heart Disease-A Systematic Review

Tools:

Journal Title:

NUTRIENTS

Volume:

Volume 12, Number 10

Publisher:

, Pages 1-15

Type of Work:

Article | Final Publisher PDF

Abstract:

Several studies indicate that oxidative stress might play a central role in the initiation and maintenance of cardiovascular diseases. It remains unclear whether ceruloplasmin acts as a passive marker of inflammation or as a causal mediator. To better understand the impact of ceruloplasmin blood levels on the risk of cardiovascular disease, and paying special attention to coronary heart disease, we conducted a search on the two most commonly used electronic databases (Medline via PubMed and EMBASE) to analyze current assessment using observational studies in the general adult population. Each study was quality rated using criteria developed by the US Preventive Services Task Force. Most of 18 eligible studies reviewed support a direct relationship between ceruloplasmin elevated levels and incidence of coronary heart disease. Our results highlight the importance of promoting clinical trials that determine the functions of ceruloplasmin as a mediator in the development of coronary heart disease and evaluate whether the treatment of elevated ceruloplasmin levels has a role in the prognosis or prevention of this condition.

Copyright information:

© 2020 by the authors.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote